Literature DB >> 17508999

Epilepsy and toxocariasis: a case-control study in Burundi.

Alessandra Nicoletti1, Alessandro Bartoloni, Vito Sofia, Antonia Mantella, Georges Nsengiyumva, Guilhem Frescaline, Pierre-Marie Preux.   

Abstract

PURPOSE: A case-control study to assess the relationship between epilepsy and toxocariasis was carried out in the Kiremba population, Burundi.
METHODS: People with epilepsy (PWE) were diagnosed according to the definition proposed by the International League Against Epilepsy (ILAE). Seizures were classified according to the classification proposed by ILAE in 1981. One control per case was selected matched by age (+/-5 years). Control subjects also lived in Kiremba, had neither neurological disorders nor kinship with the PWE. Cases and controls were assessed serologically for antibodies against Toxocara canis by an immunoblotting assay. Odds ratios (ORs) and 95% CI were determined using conditional regression analysis for matched case-control study.
RESULTS: One hundred ninety-one PWE (99 men and 92 women) and 191 age-matched controls (72 men and 112 women) were enrolled in the study. Of the 191 PWE, 113 presented partial seizures while 73 generalized seizures and five were unclassifiable. Antibodies anti T. canis were found in 114 PWE (59.7%) and in 97 controls (50.8%). Multivariate analysis (conditional logistic regression) showed a significant association between positivity for T canis and epilepsy with an adjusted OR of 2.13 (95% CI 1.18-3.83; p-value 0.01).
CONCLUSIONS: We found a significant association between toxocariasis and epilepsy. In agreement with a previous study, our finding suggests that toxocariasis may increase the risk of developing epilepsy in endemic areas and could participate to the high burden of epilepsy in tropical areas.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17508999     DOI: 10.1111/j.1528-1167.2007.01104.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  14 in total

Review 1.  Cerebral Toxocariasis: Silent Progression to Neurodegenerative Disorders?

Authors:  Chia-Kwung Fan; Celia V Holland; Karen Loxton; Ursula Barghouth
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

Review 2.  Epidemiology, causes, and treatment of epilepsy in sub-Saharan Africa.

Authors:  Awa Ba-Diop; Benoît Marin; Michel Druet-Cabanac; Edgard B Ngoungou; Charles R Newton; Pierre-Marie Preux
Journal:  Lancet Neurol       Date:  2014-10       Impact factor: 44.182

Review 3.  Incidence of epilepsy: a systematic review and meta-analysis.

Authors:  Anthony K Ngugi; S M Kariuki; C Bottomley; I Kleinschmidt; J W Sander; C R Newton
Journal:  Neurology       Date:  2011-09-06       Impact factor: 9.910

4.  Glycosaminoglycan mimetic associated to human mesenchymal stem cell-based scaffolds inhibit ectopic bone formation, but induce angiogenesis in vivo.

Authors:  Guilhem Frescaline; Thibault Bouderlique; Leyya Mansoor; Gilles Carpentier; Brigitte Baroukh; Fernando Sineriz; Marina Trouillas; Jean-Louis Saffar; José Courty; Jean-Jacques Lataillade; Dulce Papy-Garcia; Patricia Albanese
Journal:  Tissue Eng Part A       Date:  2013-07       Impact factor: 3.845

Review 5.  Do helminths cause epilepsy?

Authors:  R G Wagner; C R Newton
Journal:  Parasite Immunol       Date:  2009-11       Impact factor: 2.280

Review 6.  Zoonotic and vector-borne parasites and epilepsy in low-income and middle-income countries.

Authors:  Gagandeep Singh; Samuel A Angwafor; Alfred K Njamnshi; Henry Fraimow; Josemir W Sander
Journal:  Nat Rev Neurol       Date:  2020-05-19       Impact factor: 42.937

Review 7.  Toxocariasis and epilepsy: systematic review and meta-analysis.

Authors:  Graziella Quattrocchi; Alessandra Nicoletti; Benoit Marin; Elisa Bruno; Michel Druet-Cabanac; Pierre-Marie Preux
Journal:  PLoS Negl Trop Dis       Date:  2012-08-14

8.  Addressing the treatment gap and societal impact of epilepsy in Rwanda--Results of a survey conducted in 2005 and subsequent actions.

Authors:  Fidèle Sebera; Naasson Munyandamutsa; Dirk E Teuwen; Ibrahim Pierre Ndiaye; Amadou Gallo Diop; Azita Tofighy; Paul Boon; Peter Dedeken
Journal:  Epilepsy Behav       Date:  2015-04-30       Impact factor: 2.937

9.  Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated risk factors: cross-sectional and case-control studies.

Authors:  Anthony K Ngugi; Christian Bottomley; Immo Kleinschmidt; Ryan G Wagner; Angelina Kakooza-Mwesige; Kenneth Ae-Ngibise; Seth Owusu-Agyei; Honorati Masanja; Gathoni Kamuyu; Rachael Odhiambo; Eddie Chengo; Josemir W Sander; Charles R Newton
Journal:  Lancet Neurol       Date:  2013-01-31       Impact factor: 44.182

10.  Exposure to multiple parasites is associated with the prevalence of active convulsive epilepsy in sub-Saharan Africa.

Authors:  Gathoni Kamuyu; Christian Bottomley; James Mageto; Brett Lowe; Patricia P Wilkins; John C Noh; Thomas B Nutman; Anthony K Ngugi; Rachael Odhiambo; Ryan G Wagner; Angelina Kakooza-Mwesige; Seth Owusu-Agyei; Kenneth Ae-Ngibise; Honorati Masanja; Faith H A Osier; Peter Odermatt; Charles R Newton
Journal:  PLoS Negl Trop Dis       Date:  2014-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.